Workflow
disease treatment
icon
Search documents
Catalyst Pharmaceuticals(CPRX) - 2024 Q4 - Earnings Call Transcript
2025-02-27 14:30
Catalyst Pharmaceuticals (CPRX) Q4 2024 Earnings Call February 27, 2025 08:30 AM ET Company Participants Michael Kalb - Executive VP & CFORichard Daly - President & CEOJeff Del Carmen - Chief Commercial OfficerGary Ingenito - Chief Medical & Regulatory OfficerBenjamin Paluch - Equity Research Senior AssociateRohan Mathur - Equity Research AssociateFelix Ampomah - Senior Associate Conference Call Participants Charles Duncan - AnalystPavan Patel - AnalystAsim Rana - Equity AnalystJoseph Catanzaro - Director & ...
Supernus Pharmaceuticals(SUPN) - 2024 Q4 - Earnings Call Transcript
2025-02-25 23:56
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ET Company Participants Peter Vozzo – Investor Relations-ICR Healthcare Jack Khattar – Chief Executive Officer Tim Dec – Chief Financial Officer Conference Call Participants Andrew Tsai – Jefferies Stacy Ku – TD Cowen Annabel Samimy - Stifel David Amsellem – Piper Sandler Kristen Kluska - Cantor Fitzgerald Operator Good afternoon, and welcome to Supernus Pharmaceuticals Fourth Quarter and Full Year 2024 F ...
Tarsus Pharmaceuticals (TARS) Conference Transcript
2025-02-06 15:00
Tarsus Pharmaceuticals (TARS) Conference February 06, 2025 09:00 AM ET Company Participants Eddie Hickman - Vice PresidentJeff Farrow - CFO Eddie Hickman Good morning, everyone. Welcome back to the twenty twenty five Guggenheim's MidCap Biotech Conference. My name is Eddie Hickman and I'm one of the analysts here. I'm joined here by Tarsus Pharmaceutical CFO, Jeff Ferro. Thank you for being here, Jeff. Exciting year for Tarsus, the launch of Extemvy and the recent announcement of a new product and another n ...
CANbridge Pharmaceuticals (01228) Update / Briefing Transcript
2023-06-07 17:00
CANbridge Pharmaceuticals (01228) Update / Briefing June 07, 2023 12:00 PM ET Speaker0 Good day, ladies and gentlemen. Welcome to Cambridge's Live Marley Mainland China approval call. It's our great honor to have the following management with us here today. Doctor James Hsu, founder, chairman, and CEO of Cambridge Pharmaceuticals. Doctor. Gerald Cox, Chief Development Strategist Marcelo Tureski, Chief Commercial Officer and Glenn Hassan, Chief Financial Officer. Management team will give us a presentation o ...